v3.26.3
Share-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of share-based compensation expense driven by share-based compensation plans and programs
During the nine months ended September 30, 2026, the share-based compensation expense was mainly driven by the accelerated expense recognition due to a voluntary cancellation of 566,163 unvested stock option awards for no consideration, resulting in an expense of $11.0 million, with the remainder due to vesting of awards in compensation plans active during the period:
(in thousands)
Compensation Plan
Three Months Ended September 30, 2026
Three Months Ended September 30, 2025
Nine Months Ended September 30, 2026
Nine Months Ended September 30, 2025
ESPP
$
— 
$
741 
$
145 
$
2,199 
ESOP
— 
— 
— 
(18)
Equity Incentive Plan
2,849 
2,967 
18,605 
7,127 
Total share-based compensation expense
$
2,849 
$
3,708 
$
18,750 
$
9,308 
Of which: included in research and development expense
744 
1,190 
8,215 
2,723 
Of which: included in general and administrative expense
2,105 
2,518 
10,535 
6,585 
Schedule of nonvested share activity
ESPP
Number of Shares
Weighted-Average Grant Date Fair Value
Awards unvested as of January 1, 2026
25,902
10.00
Awards vested for the nine months ended September 30, 2026
(25,902)
10.00
Awards unvested as of September 30, 2026
—
—
Schedule of option activity for share-based payment arrangement
Equity Incentive Plan (Options)
Number of Options
Weighted-Average Exercise Price
Aggregate Intrinsic Value (in thousands)
Weighted-Average Remaining Contractual Term (in years)
Awards outstanding as of January 1, 2026
2,156,512
$
24.76
$
3,700
8.52
Awards granted for the nine months ended September 30, 2026
1,301,162
$
12.50
n/a
n/a
Awards exercised for the nine months ended September 30, 2026
(114,632)
$
6.29
n/a
n/a
Awards cancelled and forfeited for the nine months ended September 30, 2026
(736,378)
$
41.40
n/a
n/a
Awards outstanding as of September 30, 2026
2,606,664
$
14.75
$
2,773
8.67
Awards exercisable as of September 30, 2026
480,432
$
14.89
$
2,301
6.06
Summary of weighted average assumptions for awards issued
The assumptions that the Company used to determine the grant-date fair value of options granted were as follows:
Nine Months Ended September 30, 2026
Nine Months Ended September 30, 2025
Estimated fair value of the option on the grant date using Black-Scholes model ($)
8.51
29.65
Exercise price ($)
12.50
43.19
Expected term of the award on the grant date (years) (1)
6
6
Expected volatility of the share price (2)
75%
75%
Risk-free interest rate (3)
3.7%
4.4%
Expected dividend rate
—%
—%
(1) The expected term represents the period that share-based awards are expected to be outstanding.
(2) The expected volatility was derived from the historical stock volatilities of comparable peer public companies within the Company’s industry.
(3) The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the measurement date with maturities approximately equal to the expected term.
Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award
Equity Incentive Plan (Restricted Stock Awards)
Number of Shares
Weighted-Average Grant Date Fair Value
Awards unvested as of January 1, 2026
191,526
$
41.77
Awards granted for the nine months ended September 30, 2026
354,296
11.29
Awards vested for the nine months ended September 30, 2026
(47,880)
41.77
Awards unvested as of September 30, 2026
497,942
$
20.08